This is a community-generated profile. If you would like to claim it, please .
Develops drugs that modulate cortisol for treating severe diseases201-500 Employees
Corcept Therapeutics Funding
$26.2M
33 rounds
Corcept Therapeutics is active in the following markets / industries: biotechnology and pharmaceuticals. The company has secured funding across 3 rounds, totaling in an amount of $26.2M. Their most recent funding was raised on April 10, 2012.
Funding Rounds
U
$525300U
$7700000U
$18000000Investors of Corcept Therapeutics
Derek Davis
Graduated with a B.S. from Ohio State University
Passionate about Mental Health and connecting with others.